from the 10X it originally promised in 1998, although the company says its sequence covers 99% of the genome. On the basis of the data presented publicly, it is impossible to verify whether Celera's assembly is correctly orientated and ordered throughout the genome. But Celera has also produced a second map by incorporating data from the public projectwhich will increase its depth of coverage and allow it to check its shotgun assembly.
Despite the preliminary nature of both sets of data, the White House has been encouraging the two projects to bury their differences and declare their drafts complete. US politicians were appalled at the media portrayal of the sequencing project as a battle between Celera and the HGP. Clinton's aides hope that a joint announcement will end the rancour and lead to greater public recognition of the achievements of both projects.
The rapprochement between Collins and Venter was brokered by senior figures including Eric Lander, director of the Whitehead Institute at the Massachusetts Institute of Technology, one of the main sequencing centres for the HGP, and Ari Patrinos, head of biological and environmental research at the Department of Energy, who hosted meetings over beer and pizza at his home in Rockville. The agreement has four parts: Monday's choreographed joint announcement; a pledge to publish the two draft sequences, simultaneously but separately, later in the year; a loosely defined plan to hold a joint meeting of the two research teams after publication; and a promise to keep open lines of communication between the HGP and Celera.
At the White House event, Collins struck a spiritual note: "It is humbling for me and aweinspiring to realize that we have caught the first glimpse of our own instruction book, previously known only to God." Venter was philosophical: "The complexities and wonder of how the inanimate chemicals that are our genetic code give rise to the imponderables of the human spirit should keep poets and philosophers inspired for the millenniums."
For scientists working on the HGP, the main hope is that the task of finishing the genome sequence does not get subordinated to other activities. Parallels drawn with the Apollo lunar programme -which soon fizzled out after the space race was won -provide a warning. "What we most want to avoid is the fate of achieving this heroic goal at such great cost and to the neglect of the long-term goals," says Maynard Olson, a geneticist at the University of Washington in Seattle. I 
May 1998
Venter announces formation of a company -later named as Celera -to sequence human genome "within three years". Venter says he will use an ambitious 'wholegenome shotgun' method, but Celera's data access policy will not follow the Bermuda declaration.
Lander: helped to broker a genomic ceasefire.
Declan Butler and Paul Smaglik
Now the race to obtain a draft sequence of the human genome has been declared an honourable draw, attention will switch to the task of finishing the sequence and 'annotating' the entire genome -characterizing all its genes and working out their functions. The annotation is so formidable that it may need the largest Internet 'collaboratory' yet attempted.
Given that Celera has now stopped sequencing, the task of finishing the genome -in which, to ensure accuracy, each base has been sequenced 10 times over (10X coverage) -will fall to the public Human Genome Project (HGP). In that regard, says Tim Hubbard of the Sanger Centre at Hinxton, near Cambridge, the HGP got a pleasant surprise last weekend, when its data were subjected to a "brute force" computer analysis. Hubbard had expected to find that the HGP had sequenced the genome to an average depth of 5X, but instead, a figure of 7X emerged. This, and the fact that the draft seems to contain fewer gaps than expected, bodes well for finishing the genome ahead of the stated 2003 deadline, says Hubbard.
But annotation poses a much bigger challenge. The first step is to identify all of the protein-coding regions, which will give a good idea of how many genes there are. Most geneticists think the figure lies somewhere between 35,000 and 150,000. Beyond that will come detailed studies of the structure of individual genes, including their regulatory elements, and attempts to assign functions to them.
David Lipman, director of the National Center for Biotechnology Information (NCBI) in Bethesda, Maryland, believes that the draft sequence will allow researchers to use computational tools to pinpoint the position of many of the gene fragments catalogued in cDNA libraries of expressed genes. In many cases, it will then be possible to extract an entire gene from the draft sequence -and by comparison with other genes, begin to establish its function. But many biologists are unconvinced. "The current perception is that annotating finished sequence is much less difficult than annotating 'sequence in progress' ," says Richard Gibbs of Baylor College of Medicine in Houston. "And no matter how you cut it, the draft is sequence in progress."
Even with the finished sequence in hand, experience with the two human chromosomes for which this has been achievednumbers 21 and 22 -indicates that annotating the genome will be a mammoth task. "With 21 and 22 it was not possible to reliably identify and delineate all of the genes," says Philip Green, a biocomputing expert at the University of Washington in Seattle.
In the case of the genome of the fruitfly Drosophila, annotation was kickstarted by a two-week 'jamboree' held at Celera. This brought together over 40 academic fly geneticists and 50 Celera scientists, and compared the outcome of dozens of different annotation techniques. This experience should serve Celera well. "We basically trained their annotation team to annotate the human genome," observes Martin Reese, formerly of the Drosophila Genome Center at the Lawrence Berkeley National Laboratory in California and now with ValiGen, a company near Paris.
The news that Celera and HGP researchers will hold a joint scientific meeting after publishing simultaneous papers of their draft sequences (see lead story) initially raised hopes of a similar human jamboree. However, as HGP head Francis Collins pointed out to Nature, Celera cannot really share its annotation, as it will be its core product for sale to its subscribers. Rather, the meeting is expected to look at discrepancies between the public and private sequences with the goal of 'cleaning up' one another's data.
Celera has said little publicly about its annotation capacity, but it uses specialized software to combine the output of multiple gene finding tools -mostly those available to the public sector. But while Celera's annotation team is at the cutting edge, many experts argue that no single team is currently in a position to annotate the entire genome. "No one really knows how to do it completely," says John Quackenbush of The Institute for Genomic Research in Rockville, Maryland.
On the public side, annotating the genome might mean a rethink on how the HGP's data are organized. Lipman acknowledges that the main sequence database, NCBI's Genbank, has its limitations. "It does not represent what we know of biology at any given time," he says. "It only represents what the author put in." Indeed, while scientists deposit data in Genbank because many journals make this a condition for publication, some do not bother to correct and update it.
"With annotation we will need much more active curation," says Lipman. Many experts believe this may require a 'collabora-news
